SEC Form 4 · accession 0001960048-26-000011
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elvia Cowan
Officer — SVP, Finance & CAO
Period of report
Sep 8, 2026
Accepted (ET)
Sep 9, 2026 · 5:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2026 | F | 1,327 | $60.36 | D | 27,860 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.